Kidney replacement and conservative therapies in rhabdomyolysis: a retrospective analysis

BMC Nephrology

Table 3 Specific myoglobin reduction rate

	All n = 118	CVVH n = 35	CVVHD-HCO n = 31	CVVHD-ads n = 7	CVVHDF n = 9	CVVHD/SLEDD n = 23	Others^a n = 13
MRR (%)	49.5 [30.8; 72.3]	64 [38; 81]	61 [26.5; 74.3]	45 [35.3; 56.3]	33 [00; 48]	42 [20; 69]
P^#		0.7	0.266	0.787	0.161	0.708

ads. Adsorber, CVVH Continuous veno-venous hemofiltration, CVVHD Continuous veno-venous hemodialysis, CVVHDF Continuous veno-venous hemodiafiltration, HCO High cut-off, MRR Myoglobin reduction rate, SLEDD Sustained low-efficiency daily dialysis
^#Specific extracorporeal procedure compared with all other KRT modalities
^aOthers include KRT later during ICU stay and combination of more than one specific KRT: data not shown

ISSN: 1471-2369